- Exchange: New York
- Sector: Consumer, Non-cyclical
- Industry: Biotechnology
- Sub-Industry: Medical-Biomedical/Gene
Charles River Laboratories International Inc
+ Add to WatchlistCRL:US
44.7300 USD 0.1800 0.40%As of 10:29:18 ET on 05/21/2013.
Snapshot for Charles River Laboratories International Inc (CRL)
| Open: | 44.9600 | Day's Range: | 44.7000 - 45.1200 | Volume: | 105,878 |
|---|---|---|---|---|---|
| Previous Close: | 44.9100 | 52wk Range: | 31.4800 - 46.9000 | 1-Yr Rtn: | +32.14% |
Key Statistics for CRL
| Current P/E Ratio (ttm) | 18.0361 |
|---|---|
| Estimated P/E(12/2013) | 15.9936 |
| Relative P/E vs. SPX | 1.1017 |
| Earnings Per Share (USD) (ttm) | 2.4900 |
| Est. EPS (USD) (12/2013) | 2.8080 |
| Est. PEG Ratio | 1.6596 |
| Market Cap (M USD) | 2,201.90 |
| Shares Outstanding (M) | 49.03 |
| 30 Day Average Volume | 508,672 |
| Price/Book (mrq) | 3.4961 |
| Price/Sale (ttm) | 1.8810 |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 08/07/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for CRL
Company Profile & Key Executives for CRL
Charles River Laboratories International, Inc. provides research tools and support services that enable drug discovery and development. The Company pro- vides the animal research models required in research and development for new drugs, devices, and therapies. Charles River's customers include pharmaceutical and biotechnology companies, hospitals, and academic institutions.
| James C FosterChairman/President/CEO | Thomas F AckermanExec VP/CFO |
| Nancy A GillettExec VP/Chief Scientific Ofcr | David P JohstExec VP:HR/CAO/Secy/Gen Cnsl |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
CRL News
-
Industry News
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page